The company, which is being purchased by Danaher, did not report its earnings for the fourth quarter, but based on what it had previously reported for the first three quarters, revenues for the final quarter of 2010 were $986.5 million.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.